Skip to main content
logo
Amplia Therapeutics Limited (ASX:ATX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1250
+0.0050 (4.17%)
Sep 11, 2026, 12:07 PM AEST

Amplia Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
6212127151628
Market Cap Growth
-27.24%343.99%81.79%-9.41%-41.33%0.13%
Enterprise Value
34922312725
Last Close Price
0.120.230.070.070.080.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
12.8625.177.183.3613.8614.17
PB Ratio
1.563.061.291.311.041.29
P/TBV Ratio
1.953.822.084.292.092.02

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
7.1119.165.992.595.9912.57

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.010.010.000.140.140.10
Net Debt / Equity Ratio
-0.70-0.70-0.52-0.16-0.44-0.57
Net Debt / EBITDA Ratio
3.293.291.600.391.113.44
Net Debt / FCF Ratio
3.143.141.580.351.322.83
Asset Turnover
0.150.150.200.270.060.11
Quick Ratio
19.5419.547.751.933.7831.03
Current Ratio
19.7819.787.911.983.8231.18
Return on Equity (ROE)
-25.48%-25.48%-40.51%-33.05%-33.13%-22.64%
Return on Assets (ROA)
-16.29%-16.29%-22.47%-17.04%-18.20%-12.88%
Return on Capital Employed (ROCE)
-21.10%-21.10%-32.30%-39.90%-39.40%-15.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-12.51%-6.39%-24.20%-30.15%-37.85%-12.96%
FCF Yield
-14.23%-7.27%-25.36%-34.34%-32.18%-15.71%
Buyback Yield / Dilution
-52.88%-52.88%-58.35%-0.02%-33.27%-53.71%